Anna Van Acker has resigned as president of MSD China, with Kyle Tattle, president of MSD Japan, to succeed her, the unit of US pharmaceutical giant said yesterday. Van Acker will transition to a key management post within MSD’s Human Health Division, focusing on strategic projects.